financetom
Business
financetom
/
Business
/
Travel + Leisure Q2 Adjusted Earnings, Net Revenue Rise; Offers Q3, Full Year Adjusted EBITDA Guidance
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Travel + Leisure Q2 Adjusted Earnings, Net Revenue Rise; Offers Q3, Full Year Adjusted EBITDA Guidance
Jul 24, 2024 4:34 AM

07:02 AM EDT, 07/24/2024 (MT Newswires) -- Travel + Leisure ( TNL ) reported Q2 adjusted earnings Wednesday of $1.52 per diluted share, up from $1.33 a year earlier.

Analysts polled by Capital IQ expected $1.41.

Net revenue for the quarter ended on June 30 was $985 million, up from $949 million a year earlier.

Analysts surveyed by Capital IQ expected $987.2 million.

The company expects Q3 adjusted EBITDA of $235 million to $245 million. Analysts polled by Capital IQ expect $238.7 million. The company updated its full-year adjusted EBITDA to a new range of $915 million to $935 million versus the prior outlook of $910 million to $930 million. Analysts polled by Capital IQ expect $921.6 million.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Market Chatter: Kraft Heinz to Introduce New Line of Healthier Foods
Market Chatter: Kraft Heinz to Introduce New Line of Healthier Foods
Mar 17, 2026
07:11 AM EDT, 03/17/2026 (MT Newswires) -- Kraft Heinz ( KHC ) will introduce a line of healthy food products as part of a revitalization plan, Bloomberg reported Tuesday, citing an interview with Chief Executive Officer Steve Cahillane. The new products will be rolled out this month and in April, Bloomberg reported. The new products include high-protein Kraft Mac &...
Victory Capital Submits Improved, Actionable and Clearly Superior Proposal to Acquire Janus Henderson
Victory Capital Submits Improved, Actionable and Clearly Superior Proposal to Acquire Janus Henderson
Mar 17, 2026
Enhanced Financial Terms Provide Higher Value and Greater Certainty for Janus Henderson Shareholders; Materially Exceeds Value of Trian’s Contemplated Transaction Gives Special Committee Another Opportunity to Consider Improved, Superior Proposal from Independent Third Party SAN ANTONIO--(BUSINESS WIRE)-- Victory Capital Holdings, Inc. ( VCTR ) (“Victory Capital” or the “Company”) today sent a letter to the Special Committee of the...
Rhythm Pharmaceuticals Rare Obesity Drug Study Disappoints
Rhythm Pharmaceuticals Rare Obesity Drug Study Disappoints
Mar 17, 2026
Rhythm Pharmaceuticals Inc. ( RYTM ) shares are down during Tuesday’s premarket session following the Monday announcement of topline results from its EMANATE trial. EMANATE was a Phase 3 trial designed to evaluate the efficacy and safety of setmelanotide in patients with rare, genetically driven obesities of the MC4R pathway. EMANATE Trial Misses Primary Endpoints In the EMANATE trial, Rhythm...
Form 8.3
Form 8.3
Mar 17, 2026
LONDON--(BUSINESS WIRE)--   FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION   (a) Full name of discloser: Massachusetts Financial Services Company (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of...
Copyright 2023-2026 - www.financetom.com All Rights Reserved